Published in J Dermatol Sci on January 30, 2007
Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol (2008) 1.41
Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail. Biochem Pharmacol (2010) 1.36
Engineering nanomedicines for improved melanoma therapy: progress and promises. Nanomedicine (Lond) (2010) 0.85
Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation. Pharm Res (2011) 0.82
Current and future trials of targeted therapies in cutaneous melanoma. Adv Exp Med Biol (2013) 0.81
Drug delivery nanoparticles in skin cancers. Biomed Res Int (2014) 0.80
Camptothecin-Loaded Liposomes with α-Melanocyte-Stimulating Hormone Enhance Cytotoxicity Toward and Cellular Uptake by Melanomas: An Application of Nanomedicine on Natural Product. J Tradit Complement Med (2013) 0.78
Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model. Biomed Res Int (2015) 0.78
Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model. Int J Nanomedicine (2015) 0.77
Topical delivery of DNA oligonucleotide to induce p53 generation in the skin via thymidine dinucleotide (pTT)-encapsulated liposomal carrier. Int J Nanomedicine (2011) 0.75
Caprylate-conjugated Cisplatin for the development of novel liposomal formulation. AAPS PharmSciTech (2014) 0.75
Climacostol reduces tumour progression in a mouse model of melanoma via the p53-dependent intrinsic apoptotic programme. Sci Rep (2016) 0.75
Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models. Int J Nanomedicine (2016) 0.75
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics (2006) 2.25
Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. Pharm Res (2012) 1.43
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol (2009) 1.35
Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol (2002) 1.15
Lasers and microdermabrasion enhance and control topical delivery of vitamin C. J Invest Dermatol (2003) 1.06
Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells. Ultrasonics (2008) 1.03
In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production. Eur J Pharmacol (2002) 1.03
Microdermabrasion as a novel tool to enhance drug delivery via the skin: an animal study. Dermatol Surg (2006) 1.02
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm (2010) 0.99
(-)-Epicatechin-3-gallate, a green tea polyphenol is a potent agent against UVB-induced damage in HaCaT keratinocytes. Molecules (2007) 0.99
Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release (2006) 0.98
Transdermal delivery of macromolecules by erbium:YAG laser. J Control Release (2004) 0.97
Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery. J Pharm Sci (2009) 0.96
Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules (2009) 0.95
The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci (2002) 0.94
Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules. J Control Release (2011) 0.93
In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int J Pharm (2008) 0.92
Anthraquinones from Polygonum cuspidatum as tyrosinase inhibitors for dermal use. Phytother Res (2008) 0.92
Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways. Biochem Biophys Res Commun (2009) 0.91
Zeaxanthin inhibits PDGF-BB-induced migration in human dermal fibroblasts. Exp Dermatol (2010) 0.90
Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin. Hum Gene Ther (2009) 0.89
In vitro and in vivo anti-photoaging effects of an isoflavone extract from soybean cake. J Ethnopharmacol (2009) 0.88
Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J Control Release (2008) 0.88
Chrysin protects epidermal keratinocytes from UVA- and UVB-induced damage. J Agric Food Chem (2011) 0.87
Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol Pharm Bull (2008) 0.87
Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser. J Control Release (2010) 0.87
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine (2010) 0.86
Noninvasive glucose monitoring by back diffusion via skin: chemical and physical enhancements. Biol Pharm Bull (2003) 0.86
Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. AAPS J (2013) 0.86
Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res (2010) 0.86
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm (2011) 0.86
The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion. Int J Pharm (2006) 0.86
Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J Drug Target (2011) 0.85
Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J Pharm Sci (2010) 0.85
Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin. J Pharm Sci (2010) 0.85
The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Int J Pharm (2005) 0.85
Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci (2006) 0.85
Protective effects of myricetin against ultraviolet-B-induced damage in human keratinocytes. Toxicol In Vitro (2009) 0.85
Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging. Int J Nanomedicine (2012) 0.84
Physicochemical characterization and gene transfection efficiency of lipid emulsions with various co-emulsifiers. Int J Pharm (2004) 0.84
Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core. Chem Pharm Bull (Tokyo) (2011) 0.84
Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor. Angiogenesis (2012) 0.84
Evaluation of drug and sunscreen permeation via skin irradiated with UVA and UVB: comparisons of normal skin and chronologically aged skin. J Dermatol Sci (2012) 0.84
A comparison of skin delivery of ferulic acid and its derivatives: evaluation of their efficacy and safety. Int J Pharm (2010) 0.84
The influence of cardiopulmonary resuscitation without defibrillation on serum levels of cardiac enzymes: a time course study of out-of-hospital cardiac arrest survivors. Resuscitation (2005) 0.83
Initial steps in anoxic testosterone degradation by Steroidobacter denitrificans. Microbiology (2010) 0.83
Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol (2006) 0.83
Exogenous nitric oxide stimulated collagen type I expression and TGF-beta1 production in keloid fibroblasts by a cGMP-dependent manner. Nitric Oxide (2006) 0.83
Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis. J Exp Clin Cancer Res (2010) 0.83
Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study. J Control Release (2006) 0.83
In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. J Pharm Sci (2006) 0.82
Topical delivery of methotrexate via skin pretreated with physical enhancement techniques: low-fluence erbium:YAG laser and electroporation. Lasers Surg Med (2008) 0.82
Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol Pharm Bull (2013) 0.82
Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage. J Transl Med (2013) 0.82
Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat Nanotechnol (2013) 0.82
CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells. Mol Med (2012) 0.82
Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv (2014) 0.82
Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. J Microencapsul (2009) 0.82
Drug delivery and formulations for the topical treatment of psoriasis. Expert Opin Drug Deliv (2008) 0.81
Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur J Pharm Sci (2009) 0.81
Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm (2010) 0.81
Toxicological effects of cationic nanobubbles on the liver and kidneys: biomarkers for predicting the risk. Food Chem Toxicol (2012) 0.81
Skin toxicology of lead species evaluated by their permeability and proteomic profiles: a comparison of organic and inorganic lead. Toxicol Lett (2010) 0.81
Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics. Lasers Med Sci (2007) 0.80
Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation. Nitric Oxide (2006) 0.80
Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB. Life Sci (2007) 0.80
Current prodrug design for drug discovery. Curr Pharm Des (2009) 0.80
Skin permeation of small-molecule drugs, macromolecules, and nanoparticles mediated by a fractional carbon dioxide laser: the role of hair follicles. Pharm Res (2012) 0.80
(+)-Catechin prevents ultraviolet B-induced human keratinocyte death via inhibition of JNK phosphorylation. Life Sci (2006) 0.80
Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery. Pharm Res (2009) 0.80
The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A. Int J Dermatol (2008) 0.80
An in vitro study of the antimicrobial effects of indigo naturalis prepared from Strobilanthes formosanus Moore. Molecules (2013) 0.80
Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process. J Cell Physiol (2002) 0.79
Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas. Int J Biol Markers (2012) 0.79
CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression. Am J Surg (2013) 0.79
Erbium:YAG laser pretreatment accelerates the response of Bowen's disease treated by topical 5-fluorouracil. Dermatol Surg (2004) 0.79
Nitric oxide and prostaglandin E2 participate in lipopolysaccharide/interferon-gamma-induced heme oxygenase 1 and prevent RAW264.7 macrophages from UV-irradiation-induced cell death. J Cell Biochem (2002) 0.79
Nanostructured lipid carriers containing a high percentage of a Pluronic copolymer increase the biodistribution of novel PDE4 inhibitors for the treatment of traumatic hemorrhage. J Biomed Nanotechnol (2014) 0.78
Anti-inflammatory activity and percutaneous absorption of quercetin and its polymethoxylated compound and glycosides: the relationships to chemical structures. Eur J Pharm Sci (2012) 0.78
Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing : optimization of the applied dose for postoperative care. Lasers Med Sci (2013) 0.78
Delivery and targeting of nanoparticles into hair follicles. Ther Deliv (2014) 0.78
Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci (2003) 0.78
Visualizing laser-skin interaction in vivo by multiphoton microscopy. J Biomed Opt (2009) 0.78
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Nanotechnology (2010) 0.78
Efficacy of a 0.1% capsaicin hydrogel patch for myofascial neck pain: a double-blinded randomized trial. Pain Med (2012) 0.78
Milium-like syringoma: a case study on histogenesis. J Cutan Pathol (2004) 0.78
Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium. J Mol Histol (2010) 0.78
Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation. Pharm Res (2014) 0.77
Induction of TIMP-1 and HSP47 synthesis in primary keloid fibroblasts by exogenous nitric oxide. J Dermatol Sci (2006) 0.77
Activated human neutrophil response to perfluorocarbon nanobubbles: oxygen-dependent and -independent cytotoxic responses. Toxicol Lett (2011) 0.77
Functional proteomics reveals hepatotoxicity and the molecular mechanisms of different forms of chromium delivered by skin administration. Proteomics (2012) 0.77
Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study. J Pharm Pharmacol (2007) 0.77
In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios. Nanomedicine (Lond) (2011) 0.77
The delivery and antinociceptive effects of morphine and its ester prodrugs from lipid emulsions. Int J Pharm (2007) 0.77
Transdermal delivery of selegiline from alginate-Pluronic composite thermogels. Int J Pharm (2011) 0.77